title: Editorial commentary: universal antiretroviral therapy for HIV infection?
authors.forename: Jens D
authors.initials: JD
authors.lastname: Lundgren
authors.forename: Robin
authors.initials: R
authors.lastname: Wood
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D019983:Guideline Adherence / Q000941:ethics*; D015658:HIV Infections / Q000188:drug therapy*; D006297:Health Services Accessibility / Q000941:ethics*; D006801:Humans; D011785:Quality Assurance, Health Care / Q000941:ethics*
chemical_list: D044966:Anti-Retroviral Agents
keywords: antiviral therapy; risk-benefit ratio; when to start